The platform with dual labeling of ASGPR and GPC3 had an effective ability in detecting HCC CTCs with a small number of peripheral blood samples in clinical diagnosis. Pang et al., 2018 (90). This evidence concerns the gene GPC3 and hepatocellular carcinoma.